The GLP-1 analogue insurance standard is largely improved

The GLP(glucagon-like peptide)-2 analogue, a diabetes treatment, has met a chance to be expanded in prescriptions by improvement of the health insurance standard.

The Ministry of Health and Welfare, on the 15^th, has partially revised and newly created the health insurance standard of GLP-1 analogues through an administrative notice for the Amendment for ‘details of the health insurance applica...